Modernizing Cell Banking: Scalable, Consistent, And Automated

The success of a biomanufacturing seed train often hinges on the quality of the initial cell bank, yet manual handling and open processing steps remain common points of failure. These gaps do more than just increase contamination risk; they introduce variability that compromises downstream yields and slows the path to GMP scale-up. Adopting closed, automated systems allows for high-density banking and precise concentration without the shear stress associated with legacy centrifuges. These advancements ensure that even sensitive cell types, such as iPSCs, maintain high viability post-thaw.

Transitioning to a recipe-driven, single-use approach standardizes performance across global manufacturing sites. Explore the full article to learn how to modernize your banking strategy for greater consistency and scalability.